Integra LifeSciences Receives FDA 510 ( k ) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( NASDAQ:IART ) , a leading global medical technology company, is pleased to announce the FDA 510 ( k ) clearance for use of its CUSA® Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries.
Integra LifeSciences ( IART ) Q3 Earnings Beat Estimates
Integra (IART) delivered earnings and revenue surprises of +25.58% and -3.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Integra LifeSciences Reports Third Quarter 2025 Financial Results
PRINCETON, N.J., Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( Nasdaq: IART ) , a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025.
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
MELVILLE, N.Y., Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- BioRestorative Therapies, Inc. ( "BioRestorative", "BRTX" or the "Company" ) ( NASDAQ: ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that Crystal Romano has joined its management team.
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
MELVILLE, N.Y., Oct. 22, 2025 ( GLOBE NEWSWIRE ) -- BioRestorative Therapies, Inc. ( "BioRestorative", "BRTX" or the "Company" ) ( NASDAQ:BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today announced that Crystal Romano has joined its management ...
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., Oct. 15, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( NASDAQ:IART ) , a leading global medical technology company, will release third quarter 2025 financial results on Thursday, October 30, 2025, prior to the market open.
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons ( CNS ) Annual Meeting
Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post ...
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART today announced the appointment of Dr. Raymond Turner as its new corporate vice president and chief medical officer.
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART shows strong demand in neurosurgery and Tissue Technologies but faces macro and liquidity challenges.
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
PRINCETON, N.J., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( Nasdaq: IART ) , a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor ...
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART, a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor healthcare ...
Integra ( IART ) Q2 Revenue Beats by 5%
Integra LifeSciences ( NASDAQ:IART ) , a medical technology company specializing in neurosurgery, reconstructive, and tissue technologies, released its results for Q2 2025 on July 31, 2025. The most important takeaway was that the company's revenue ( GAAP ) exceeded expectations, coming in at ...
Integra LifeSciences ( IART ) Beats Q2 Earnings and Revenue Estimates
Integra (IART) delivered earnings and revenue surprises of +4.65% and +5.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Integra LifeSciences Reports Second Quarter 2025 Financial Results
PRINCETON, N.J., July 31, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( Nasdaq: IART ) , a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2025.
Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
PRINCETON, N.J., July 14, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) , a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prior to the market open.
IART Stock May Rise on First Enrollment in AERA Pediatric Registry
Integra enrolls first pediatric patient in AERA registry to evaluate real-world use of its ETBD system and expand ENT market presence.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART - Integra Lifesciences ( NASDAQ:IART )
NEW YORK, June 15, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ( "Integra" or the "Company" ) IART. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART - Integra Lifesciences ( NASDAQ:IART )
NEW YORK, June 06, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ( "Integra" or the "Company" ) IART. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Veracyte ( VCYT ) Down 13.6% Since Last Earnings Report: Can It Rebound?
Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Integra ( IART ) Up 2.3% Since Last Earnings Report: Can It Continue?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is the Options Market Predicting a Spike in Integra LifeSciences Stock?
Investors need to pay close attention to Integra LifeSciences stock based on the movements in the options market lately.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART - Integra Lifesciences ( NASDAQ:IART )
NEW YORK, May 28, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ( "Integra" or the "Company" ) IART. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut
IART's first-quarter 2025 earnings lag the consensus mark. Q2 revenue projections are bleak.
Attention Long-Term Shareholders of Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) ; Mercury Systems, Inc. ( NASDAQ: MRCY ) ; Monolithic Power Systems, Inc. ( NASDAQ: MPWR ) ; and Virtu Financial Inc. ( NASDAQ: VIRT ) : Grabar Law Office is Investigating Claims on Your Behalf - Integra Lifesciences ( NASDAQ:IART ) , Monolithic Power Systems ( NASDAQ:MPWR )
PHILADELPHIA, May 06, 2025 ( GLOBE NEWSWIRE ) -- Current Integra LifeSciences Holdings Corp. IART shareholders who have held the stock since on or before March 11, 2019, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved ...
Crude Oil Falls Over 2%; ISM Services PMI Rises In April - Hyperscale Data ( AMEX:GPUS ) , BioCryst Pharma ( NASDAQ:BCRX )
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 0.2% on Monday. The Dow traded up 0.21% to 41,406.25 while the NASDAQ fell 0.41% to 17,903.64. The S&P 500 also fell, dropping, 0.26% to 5,671.90. Industrials shares rose by 0.2% on Monday.
Long-Term Shareholders Have Rights - If You Hold Akero Therapeutics, Inc. ( NASDAQ: AKRO ) ; Integra Lifesciences Holdings Corporation ( NASDAQ: IART ) ; Mercury Systems, Inc. ( NASDAQ: MRCY ) ; or Virtu Financial Inc. ( NASDAQ: VIRT ) , Contact Grabar Law Office - Integra Lifesciences ( NASDAQ:IART ) , Akero Therapeutics ( NASDAQ:AKRO )
PHILADELPHIA, May 05, 2025 ( GLOBE NEWSWIRE ) -- Akero Therapeutics, Inc. AKRO: Grabar Law Office is investigating whether certain officers and directors of Akero breached their fiduciary duties owed to the company. If you have held Akero Therapeutics, Inc.
Integra LifeSciences ( IART ) Q1 Earnings Miss Estimates
Integra (IART) delivered earnings and revenue surprises of -4.65% and 0.13%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Integra LifeSciences Reports First Quarter 2025 Financial Results
PRINCETON, N.J., May 05, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) , a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025.
Notice to Long-Term Shareholders of Integra Lifesciences Holdings Corporation ( NASDAQ: IART ) ; and Monolithic Power Systems, Inc. ( NASDAQ: MPWR ) ; NAPCO Security Technologies, Inc. ( NASDAQ: NSSC ) ; and Virtu Financial Inc. ( NASDAQ: VIRT ) : Grabar Law Office Investigates Claims on Your Behalf - Integra Lifesciences ( NASDAQ:IART ) , Monolithic Power Systems ( NASDAQ:MPWR )
PHILADELPHIA, April 25, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. IART breached their fiduciary duties owed to the Company. Current Integra LifeSciences Holdings Corp.
Notice to Long-Term Shareholders of BioAge Labs, Inc. ( NASDAQ: BIOA ) ; Driven Bands Holdings, Inc. ( NASDAQ: DRVN ) ; Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) ; and Monolithic Power Systems, Inc. ( NASDAQ: MPWR ) : Grabar Law Office Investigates Claims on Your Behalf - Bioage Labs ( NASDAQ:BIOA ) , Driven Brands Hldgs ( NASDAQ:DRVN )
PHILADELPHIA, April 24, 2025 ( GLOBE NEWSWIRE ) -- If you have held BioAge Labs, Inc. BIOA shares continuously since on or shortly after its September 26, 2024 IPO, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you.
Notice to Long-Term Shareholders of BioAge Labs, Inc. ( NASDAQ: BIOA ) ; Driven Bands Holdings, Inc. ( NASDAQ: DRVN ) ; Integra Lifesciences Holdings Corporation ( NASDAQ: IART ) ; and Monolithic Power Systems, Inc. ( NASDAQ: MPWR ) : Grabar Law Office Investigates Claims on Your Behalf - Bioage Labs ( NASDAQ:BIOA ) , Driven Brands Hldgs ( NASDAQ:DRVN )
PHILADELPHIA, April 22, 2025 ( GLOBE NEWSWIRE ) -- If you have held BioAge Labs, Inc. BIOA shares continuously since on or shortly after its September 26, 2024 IPO, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you.
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
PRINCETON, N.J., April 18, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) , a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open.
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., April 18, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART, a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open.
Attention Long-Term Shareholders of Axsome Therapeutics, Inc. ( NASDAQ: AXSM ) ; Driven Bands Holdings, Inc. ( NASDAQ: DRVN ) ; Integra Lifesciences Holdings Corporation ( NASDAQ: IART ) ; and Virtu Financial Inc. ( NASDAQ: VIRT ) : Grabar Law Office Investigates Claims on Your Behalf - Driven Brands Hldgs ( NASDAQ:DRVN ) , Axsome Therapeutics ( NASDAQ:AXSM )
PHILADELPHIA , April 11, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. AXSM as an underlying securities fraud class action has survived a motion to dismiss the complaint.
Do Options Traders Know Something About Integra ( IART ) Stock We Don't?
Investors need to pay close attention to Integra (IART) stock based on the movements in the options market lately.
Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. ( NASDAQ: DRVN ) ; General Motors Company ( NYSE: GM ) ; Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) ; and ModivCare, Inc. ( NASDAQ: MODV ) : Act Now as Grabar Law Office Is Investigating Claims on Your Behalf - Driven Brands Hldgs ( NASDAQ:DRVN ) , General Motors ( NYSE:GM )
PHILADELPHIA, April 07, 2025 ( GLOBE NEWSWIRE ) -- A securities fraud class action complaint against Driven Brands Holdings, Inc. DRVN has survived defendants, attempts to dismiss the complaint. Grabar Law Office is now investigating claims on behalf of long-term Driven Brands shareholders.
Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. ( NASDAQ: DRVN ) ; Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) ; ModivCare, Inc. ( NASDAQ: MODV ) ; and Virtu Financial Inc. ( NASDAQ: VIRT ) : Grabar Law Office is Investigating Claims on Your Behalf - Driven Brands Hldgs ( NASDAQ:DRVN ) , Integra Lifesciences ( NASDAQ:IART )
PHILADELPHIA, April 04, 2025 ( GLOBE NEWSWIRE ) -- A securities fraud class action complaint against Driven Brands Holdings, Inc. DRVN has survived defendants, attempts to dismiss the complaint. Grabar Law Office is now investigating claims on behalf of long-term Driven Brands shareholders.
Global Bariatric Surgeries Market to Hit USD 27.64 Billion by 2030, Fueled by Rising Demand for Minimally Invasive Techniques - The Insight Partners
US & Canada, April 01, 2025 ( GLOBE NEWSWIRE ) -- US & Canada, Mar, 21, 2025 ( GlobeNewswire ) -- According to a comprehensive report from The Insight Partners, "Bariatric Surgeries Market Size and Forecast ( 2020 - 2030 ) , Global and Regional Share, Trend, and Growth Opportunity Analysis ...
Integra ( IART ) Down 7.5% Since Last Earnings Report: Can It Rebound?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Alert to Long-Term Shareholders of Holley Inc. ( NYSE: HLLY ) ; Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) ; Outset Medical, Inc. ( NASDAQ: OM ) ; and Virtu Financial Inc. ( NASDAQ: VIRT ) : Grabar Law Office Is Investigating Claims on Your Behalf - Holley ( NYSE:HLLY ) , Integra Lifesciences ( NASDAQ:IART )
PHILADELPHIA, March 27, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating whether Officers and Directors of Holley Inc HLLY breached their fiduciary duties owed to the Company. Current Holley Inc.
Is This the Right Time to Hold Integra Stock in Your Portfolio?
IART stays on investors' radar courtesy of its strong prospects in the CSS segment and international growth.
Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. ( NASDAQ: DRVN ) ; Holley Inc. ( NYSE: HLLY ) ; Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) ; and Virtu Financial Inc. ( NASDAQ: VIRT ) : Grabar Law Office Is Investigating Claims On Your Behalf - Holley ( NYSE:HLLY ) , Driven Brands Hldgs ( NASDAQ:DRVN )
PHILADELPHIA, March 25, 2025 ( GLOBE NEWSWIRE ) -- A securities fraud class action complaint against Driven Brands Holdings, Inc. DRVN has survived defendants, attempts to dismiss the complaint. Grabar Law Office is now investigating claims on behalf of long-term Driven Brands shareholders.
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. ( Nasdaq: AKRO ) ; Driven Brands Holdings, Inc. ( Nasdaq: DRVN ) ; Integra Lifesciences Holdings Corporation ( Nasdaq: IART ) ; and Kyverna Therapeutics, Inc. ( Nasdaq: KYTX ) : Grabar Law Office is Investigating Claims on Your Behalf - Driven Brands Hldgs ( NASDAQ:DRVN ) , Akero Therapeutics ( NASDAQ:AKRO )
PHILADELPHIA, March 24, 2025 ( GLOBE NEWSWIRE ) -- Akero Therapeutics, Inc. AKRO: Grabar Law Office is investigating whether certain officers and directors of Akero breached their fiduciary duties owed to the company. If you have held Akero Therapeutics, Inc.
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
PRINCETON, N.J., March 13, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation ( NASDAQ: IART ) , a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual ...
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Integra Lifesciences ( NASDAQ:IART )
PRINCETON, N.J., March 13, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART, a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer ...
Neurosurgery Market Size to Reach USD 6.8 Billion by 2034, Growing at 4.5% CAGR with Technological Advancements and Rising Focus on Personalized Medicine - Analysis by TMR
Wilmington, Delaware, Transparency Market Research Inc. -, March 12, 2025 ( GLOBE NEWSWIRE ) -- Advancements in robotic-assisted surgery and neuroimaging are driving innovation in brain and spine procedures. The Global Neurosurgery Industry was valued at US$ 4.2 billion in 2023.
Neurology Devices Market is Expected to Reach USD 22,335.5 Million by 2035, Growing at 6.7% CAGR | Fact.MR Report
Rockville, MD, March 10, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global neurology devices market is estimated to reach a valuation of USD 11,678 million in 2025 and is expected to grow at a CAGR of 6.7% during the forecast ...
Amniocentesis Needle Market Set to Surge at 3.2% CAGR, to Reach US$ 239.8 Million by 2035 | Fact.MR Report
Rockville, MD, March 06, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global amniocentesis needle market is estimated to reach a valuation of USD 175.0 million in 2025 and is expected to grow at a CAGR of 3.2 % during the forecast ...
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up
IART delivers better-than-expected earnings in the fourth quarter of 2024.
Integra LifeSciences ( IART ) Surpasses Q4 Earnings Estimates
Integra (IART) delivered earnings and revenue surprises of 14.12% and 0.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
